Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Qilu Pharmaceutical and Peptron Sign License Agreement for anti-MUC1 ADC 2021-04-16 20:00
Transcenta Announced Presentation of Preclinical Data of TST005 at 2021 AACR Virtual Annual Meeting 2021-04-16 08:00
New Pathway Launched for Pioneering Life Science Companies Seeking Japanese Market Entry 2021-04-15 21:00
Juniper Biologics Announces the Appointment of Raman Singh as Chief Executive 2021-04-15 16:30
Adlai Nortye Announces First Patient Dosed in Global Phase III Clinical Trial of Buparlisib (AN2025) in Combination with Paclitaxel for the Treatment of Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma 2021-04-15 09:00
Kintor Pharmaceutical and Visum Announced Strategic Partnership to Expand Proxalutamide Manufacturing 2021-04-14 22:18
BioVaxys Announces Final Clinical trial results of HPV product from EU partner ProCare Health Iberia published by American Society for Colposcopy and Cervical Pathology 2021-04-14 20:00
Moleac Announces US FDA Approval of IND Application for Phase 1 Study of MLC1501 Programme in Post-Traumatic Brain Injury Recovery 2021-04-14 19:15
GeneLeap Presents New Preclinical Data for Hydrogel Encapsulated TLR9 Agonist at AACR 2021 2021-04-14 14:54
Molecular Matrix and GenScript Partner to Launch SARS-CoV-2 Neutralizing Antibody Testing Service for Public 2021-04-13 19:30
ILC Dover Defines the Future of Sterile Manufacturing with the soloPURE™ Flexible Aseptic Isolator 2021-04-13 18:00
WuXi Biologics Receives 2021 Asia-Pacific Bioprocessing Excellence Award from IMAPAC 2021-04-13 17:00
Ascentage Pharma Releases Preclinical Data of Its Core Drug Candidates at AACR Annual Meeting 2021, with Results Signifying the Potential of Multiple Combination Therapies in Cancer 2021-04-13 08:28
Alphamab Oncology Presented Clinical Data of KN046 Combined with Nab-paclitaxel in the Treatment of mTNBC at AACR 2021 2021-04-13 08:15
Innovent and Lilly Release Phase 3 Results of TYVYT® (Sintilimab Injection) as a Second-Line Treatment for Squamous Non-Small Cell Lung Cancer at AACR Annual Meeting 2021 2021-04-13 08:00
Island Pharmaceuticals Limited to list on the ASX today following oversubscribed A$7.5m IPO 2021-04-13 04:00
Terumo is building a Global Therapeutic Interventional Oncology team to offer more therapeutic solution to cancer patients 2021-04-12 22:25
Seegene begins exporting its latest COVID-19 variant tests around the world to help contain spread of pandemic 2021-04-12 20:53
PharmAbcine presents the non-clinical data of PMC-309 at AACR 2021 2021-04-12 20:00
OOOPDS - a surgical planning software received TFDA Class-II medical device certification developed by Taiwan Main Orthopaedic Biotechnology Co., Ltd. 2021-04-12 19:50
1 249 250 251 252 253 451